Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
Key facts
- Where
- Halifax and Toronto, CanadaSee the 2 sites
Where in Canada
- IWK Health CentreHalifax, CanadaContact: Cora FanningTaking people
- North York General HospitalToronto, CanadaContact: Clare GibbonsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Sequenom, Inc.
- Trial code
- NCT01429389
- Record updated
- 9 September 2026
- Original description
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.Read full original descriptionShow less
Collection of Whole Blood Specimens From Pregnant Women at Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Inclusion: pregnant between 10 and 22 weeks gestation; 18 years of age or older; provides signed and dated informed consent; subject is at increased risk for fetal aneuploidy; subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis; subject agrees to provide the genetic results of the invasive procedure.
Exclusion: Previous sample donation under this protocol; Fetal demise at time of specimen sampling.